US Health Panel Urges Restarting J&J COVID-19 Vaccination

A U.S. health panel says it's time to resume use of Johnson & Johnson's COVID-19 vaccine, despite a very rare risk of blood clots.

Video Transcript

- Time on the Johnson Johnson vaccine, a CDC panel has recommended that that shot can be used again.

- But from now on, the vaccine will come with a safety warning. The government paused the use of the Johnson & Johnson vaccines 10 days ago after six women developed rare blood clots. Nine more cases have now been confirmed and three of the women have died.

New packaging will warn women under 50 about the risk of rare but serious blood clots.

What's unclear right now, though, is just how soon people will start getting the J&J shot again.